1.
Atli E, Kalkan R, Mail C, Eker D, Demirci U, Demir S, Yalcintepe S, Kirkizlar HO, Atli E, Gurkan H, Demir AM. THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES: Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies. Mediterr J Hematol Infect Dis [Internet]. 2021 Jan. 1 [cited 2021 Oct. 17];13(1):e2021013. Available from: https://mjhid.org/index.php/mjhid/article/view/4432